Author

L. Matarazzo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

J.-C. Sirard· 2 shared C. Carnoy· 1 shared C. Kloft· 1 shared D. Soulard· 1 shared F. Casilag· 1 shared F. P. Bock· 1 shared J. Denereaz· 1 shared J.-W. Veening· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J.-C. Sirard

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A conserved antigen induces respiratory Th17-mediated serotype-independent protection against pneumococcal superinfection

X. Liu, L. Van Maele, L. Matarazzo, D. Soulard, V. Alves Duarte da Silva, V. de Bakker, J. Denereaz, F. P. Bock, M. Taschner, S. Gruber, V. Nizet, J.-C. Sirard, J.-W. Veening

The paper identifies a conserved antigen, LafB, that provides serotype-independent protection against pneumococcal superinfection via Th17 cells, independent of antibodies.

bioRxiv · Jul 7, 2023 · PreprintMicrobiology

Boosting Toll-like receptor 4 signaling enhances the therapeutic outcome of antibiotic therapy in pneumococcal pneumonia

F. Casilag, S. Franck, L. Matarazzo, M. Figeac, R. Michelet, C. Kloft, C. Carnoy, J.-C. Sirard

This study shows that combining TLR4 activation with antibiotics improves bacterial clearance and survival in pneumococcal pneumonia.

bioRxiv · Feb 18, 2020 · PreprintMicrobiology